Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
We identified an autosomal recessive infantile-onset symptomatic epilepsy syndrome associated with developmental stagnation and blindness. Assuming a founder effect in a large Old Order Amish pedigree, we carried out a genome-wide screen for linkage and identified a single region of homozygosity on chromosome 2p12-p11.2 spanning 5.1 cM (maximum lod score of 6.84). We sequenced genes in the region and identified a nonsense mutation in SIAT9, which is predicted to result in the premature termination of the GM3 synthase enzyme (also called lactosylceramide alpha-2,3 sialyltransferase). GM3 synthase is a member of the sialyltransferase family and catalyzes the initial step in the biosynthesis of most complex gangliosides from lactosylceramide. Biochemical analysis of plasma glycosphingolipids confirmed that affected individuals lack GM3 synthase activity, as marked by a complete lack of GM3 ganglioside and its biosynthetic derivatives and an increase in lactosylceramide and its alternative derivatives. Although the relationship between defects in ganglioside catabolism and a range of lysosomal storage diseases is well documented, this is the first report, to our knowledge, of a disruption of ganglioside biosynthesis associated with human disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Munro, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00882-1 · Cited by 1,514
Enhanced insulin sensitivity in mice lacking ganglioside GM3
Yamashita, T., Hashiramoto, A., Haluzik, M., Mizukami, H., Beck, S., Norton, A., Kono, M., Tsuji, S., Daniotti, J. L., Werth, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0635898100 · Cited by 531
Mice Expressing Only Monosialoganglioside GM3 Exhibit Lethal Audiogenic Seizures
Kawai, H., Allende, M. L., Wada, R., Kono, M., Sango, K., Deng, C., Miyakawa, T., Crawley, J. N., Werth, N., Bierfreund, U., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000847200 · Cited by 227
Gangliosides as modulators of cell function
Zeller, C. B., & Marchase, R. B. (1992) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1992.262.6.c1341 · Cited by 208
Biosynthesis and degradation of mammalian glycosphingolipids
Sandhoff, K., & Kolter, T. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1265 · Cited by 183
Neville, D. C. A., Coquard, V., Priestman, D. A., te Vruchte, D. J. M., Sillence, D. J., Dwek, R. A., Platt, F. M., & Butters, T. D. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.03.051 · Cited by 178
Self-citationTraveling for the glycosphingolipid path
Hakomori, S.-I. (2000) · Glycoconjugate Journal · doi:10.1023/a:1011086929064 · Cited by 178
Wraith, J. E. (2002) · Seminars in Neonatology · doi:10.1053/siny.2001.0088 · Cited by 166
Refractory Skin Injury in Complex Knock-out Mice Expressing Only the GM3 Ganglioside
Inoue, M., Fujii, Y., Furukawa, K., Okada, M., Okumura, K., Hayakawa, T., Furukawa, K., & Sugiura, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201631200 · Cited by 107
Glycosphingolipid functions: insights from engineered mouse models
Proia, R. L. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1268 · Cited by 84
pH-independent retrograde targeting of glycolipids to the Golgi complex
Schapiro, F. B., Lingwood, C. A., Furuya, W., & Grinstein, S. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.2.c319 · Cited by 73
Glycosphingolipids of human plasma
Kundu, S. K., Diego, I., Osovitz, S., & Marcus, D. M. (1985) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(85)90179-1 · Cited by 72
Conserved Cysteines in the Sialyltransferase Sialylmotifs Form an Essential Disulfide Bond
Datta, A. K., Chammas, R. J., & Paulson, J. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010542200 · Cited by 68
GM3(Hematoside) Sphingolipodystrophy
Max, S. R., Maclaren, N. K., Brady, R. O., Bradley, R. M., Rennels, M. B., Tanaka, J., García, J. H., & Cornblath, M. (1974) · New England Journal of Medicine · doi:10.1056/nejm197410312911802 · Cited by 52
Lipid membrane domains in cell surface and vacuolar systems
Kobayashi, T., & Hirabayashi, Y. (2000) · Glycoconjugate Journal · doi:10.1023/a:1026528921085 · Cited by 33
Impact of our understanding of the genetic aetiology of epilepsy
Gardiner, R. M. (2000) · Journal of Neurology · doi:10.1007/s004150050598 · Cited by 33
Zebda, N., Pedron, S., Rebbaa, A., Portoukalian, J., & Berthier‐Vergnes, O. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00234-z · Cited by 31
Evaluation of the efficiency of an assay procedure for gangliosides in human serum
Negroni, E., Chigorno, V., Tettamanti, G., & Sonnino, S. (1996) · Glycoconjugate Journal · doi:10.1007/bf00731466 · Cited by 21
Human serum gangliosides in hypercholesterolemia, before and after extracorporeal elimination of LDL
Hans‐Jürgen, S. E. N. N., Orth, M., Fitzke, E., Köster, W., Wieland, H., & Gerok, W. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90235-9 · Cited by 21
Izumi, T., Ogawa, T., Koizumi, H., & Fukuyama, Y. (1993) · Pediatric Neurology · doi:10.1016/0887-8994(93)90066-l · Cited by 19
Ganglioside changes associated with temporal lobe epilepsy in the human hippocampus.
Rk, Y., Ja, H., Macala, L. J., & Dd, S. (1987) · PubMed Central · Cited by 18
Possible role of gangliosides in epilepsy: effects of epileptic seizures on cerebral gangliosides.
Rk, Y., & Gh, G. (1975) · PubMed · Cited by 8
Cited by
Glycosylation in Cellular Mechanisms of Health and Disease
Ohtsubo, K., & Marth, J. D. (2006) · Cell · doi:10.1016/j.cell.2006.08.019 · Cited by 2,788
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“phenotypes (405, 406), humans with similar defects suffer from severe multisystem disease (407, 408).”
BackgroundSialic acids in human health and disease
Varki, A. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.06.002 · Cited by 999
Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics
Merrill, A. H. (2011) · Chemical Reviews · doi:10.1021/cr2002917 · Cited by 785
Schnaar, R. L., Gerardy-Schahn, R., & Hildebrandt, H. (2014) · Physiological Reviews · doi:10.1152/physrev.00033.2013 · Cited by 745
Metadata
- Authors
- Simpson, M. A., Cross, H., Proukakis, C., Priestman, D. A., Neville, D. C. A., Reinkensmeier, G., Wang, H., Wiznitzer, M., Gurtz, K., Verganelaki, A., Pryde, A., Patton, M. A., Dwek, R. A., Butters, T. D., Platt, F. M., & Crosby, A. H.
- Affiliations
- University of London (GB)
- University of Arizona (US)
- University of Oxford (GB)
- Rainbow Babies & Children's Hospital (US)
- Corresponding author
- Crosby, Andrew H
- ORCID
- Venue
- Nature Genetics
- Published
- 2004-10-24
- Volume
- 36
- Issue
- 11
- Pages
- 1225-1229
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2161292836
- Cited by
- 389
- References
- 22
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 17 · 2023: 20 · 2022: 25 · 2021: 18 · 2020: 25 · 2019: 15 · 2018: 29 · 2017: 11 · 2016: 19 · 2015: 16 · 2014: 27 · 2013: 19 · 2012: 18
- FWCI
- 8.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Research to Prevent Blindness
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- GM3 synthase, loss-of-function mutations, autosomal recessive inheritance, founder effect, Old Order Amish, ganglioside biosynthesis, GM3 ganglioside, lactosylceramide, glycosphingolipids, blindness, sialyltransferase, linkage mapping
- MeSH terms
- Blindness, Developmental Disabilities, Chromosomes, Human, Pair 2, Epilepsy, Female, G(M3) Ganglioside, Genes, Recessive, Glycosphingolipids, Humans, Infant, Infant, Newborn, Male, Pedigree, Sialyltransferases, Syndrome, Codon, Nonsense, Founder Effect
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.